Topics

Glioblastoma | Treatment | Targeted therapy | Pemigatinib

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Pemigatinib

Liu YT, Chen YH, Chang CH, Liang HT.
Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature.
Neurooncol Adv. 2024 May 14;6(1):vdae072. doi: 10.1093/noajnl/vdae072. PMID: 38845691. Case report; Review. ˍ

Deshors P, Kheil Z, Ligat L, Gouazé-Andersson V, Cohen-Jonathan Moyal E.
FGFR inhibition as a new therapeutic strategy to sensitize glioblastoma stem cells to tumor treating fields.
Cell Death Discov. 2025 Jun 4;11(1):265. doi: 10.1038/s41420-025-02542-5. PMID: 40467542. Laboratory investigation. ˍ